Prevention of Infective Endocarditis Guidelines From the American Heart Association A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group

http://circ.ahajournals.org/content/116/15/1736.full.pdf

Desde 2007 estima-se que houve uma redução de 80% na prescrição de antibiótico na prevenção da Endocardite Infecciosa. 

Mas ainda hoje em dia muitos profissionais continuam medicando sem necessidade, somente nas condições deve-se indicar uma profilaxia. Não seja mais um a medicar sem necessidade.

Antibiotic prophylaxis with dental procedures is reasonable only  for patients with cardiac conditions associated with the  highest risk of adverse outcomes from endocarditis, including:

1. Prosthetic cardiac valve or prosthetic material used in valve repair.

2. Previous endocarditis.

3. Congenital heart disease only in the following categories:

– Unrepaired cyanotic congenital heart disease, including those with palliative shunts and conduits

– Completely repaired congenital heart disease with prosthetic material or device, whether placed by surgery or catheter intervention, during the first six months after the procedure*

 - Repaired congenital heart disease with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibit endothelialization)

4 Cardiac transplantation recipients with cardiac valvular disease

*Prophylaxis is reasonable because endothelialization of prosthetic material occurs within six months after the procedure